Next Article in Journal
Polymethoxy-1-Alkenes Screening of Chlorella and Spirulina Food Supplements Coupled with In Vivo Toxicity Studies
Next Article in Special Issue
Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders
Previous Article in Journal
Morphological, Pathogenic and Toxigenic Variability in the Rice Sheath Rot Pathogen Sarocladium Oryzae
Previous Article in Special Issue
Effect of Botulinum Toxin A on Bladder Pain—Molecular Evidence and Animal Studies
Open AccessReview

Can Botulinum Toxin A Play A Role In Treatment Of Chronic Pelvic Pain Syndrome In Female Patients?—Clinical and Animal Evidence

Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Gung Road, Taipei 114, Taiwan
*
Author to whom correspondence should be addressed.
Toxins 2020, 12(2), 110; https://doi.org/10.3390/toxins12020110
Received: 31 December 2019 / Revised: 5 February 2020 / Accepted: 7 February 2020 / Published: 10 February 2020
Chronic pelvic pain (CPP) is defined as chronic pain and inflammation in the pelvic organs for more than six months. There are wide ranges of clinical presentations, including pelvic pain, painful intercourse, irritable bowel syndrome, and pain during urinating. Chronic pelvic pain syndrome (CPPS) is a subdivision of CPP, and the pain syndrome may be focused within a single organ or more than one pelvic organ. As there is uncertain pathogenesis, no standard treatment is currently available for CPPS. Botulinum toxin A (BoNT-A) is a potent neurotoxin that blocks acetylcholine release to paralyze muscles. Intravesical BoNT-A injection can reduce bladder pain in patients with interstitial cystitis/bladder pain syndrome. BoNT-A injected into the pelvic floor muscles of women has also been reported to improve chronic pain syndrome. Due to the reversible effect of BoNT-A, repeated injection appears to be necessary and effective in reducing symptoms. Adverse effects of BoNT-A may worsen the preexisting conditions, including constipation, stress urinary incontinence, and fecal incontinence. This review summarizes the evidence of BoNT-A treatment for CPPS in animal studies and clinical studies regarding the therapeutic effects of BoNT-A for CPPS in female patients.
Keywords: botulinum toxin A; chronic pelvic pain syndrome; pelvic pain botulinum toxin A; chronic pelvic pain syndrome; pelvic pain
MDPI and ACS Style

Chen, C.-L.; Meng, E. Can Botulinum Toxin A Play A Role In Treatment Of Chronic Pelvic Pain Syndrome In Female Patients?—Clinical and Animal Evidence. Toxins 2020, 12, 110.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop